Anika Therapeutics financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$26.47M $29.83M $26.84M $30.83M $35.78M $40.14M $55.56M $64.78M $71.36M $75.08M $105.60M $93.00M $103.38M $113.42M $105.56M $114.61M $130.46M $147.79M $156.24M $166.66M $0.00M
GM % Gross Margin %
62.41% 62.65% 58.58% 61.46% 63.14% 65.94% 57.11% 58.65% 59.38% 69.68% 80.18% 77.36% 76.76% 75.87% 70.37% 74.92% 61.41% 82.94% 61.94% 62.30% 0.00%
OM Operating Margin
24.14% 28.66% 20.22% 21.37% 11.81% 19.28% 13.57% 21.56% 31.19% 43.05% 58.19% 52.51% 48.95% 40.32% 26.48% 32.72% 1.04% -0.12% -10.37% -7.02% 0.00%
EPS Earnings Per Share
$0.52 $0.41 $0.53 $0.32 $0.32 $0.62 $0.93 $1.38 $2.51 $2.01 $2.15 $1.96 $1.27 $2.05 $0.71 $-0.02 $-0.49 $-0.30 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0.00% 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.00% 0 0 0
Sha. Shares
10.2m 10.5m 10.73m 11.17m 11.38m 11.44m 13.48m 12.82m 13.3m 13.77m 14.5m 14.64m 14.62m 14.66m 14.21m 14.27m 14.21m 220m 14.52m 0m 14.64m
OCF Operating Cash Flow
$23.82M $6.45M $2.00M $4.49M $3.41M $3.09M $7.85M $10.17M $10.55M $25.17M $39.98M $39.91M $24.45M $40.81M $34.92M $37.01M $13.07M $-4822000.00M $4.41M $-1.79M $0.00M
FCF Free Cash Flow
$23.35M $4.85M $0.69M $-9.27M $-12.84M $-0.87M $5.07M $8.77M $9.04M $24.72M $38.43M $29.84M $9.79M $31.83M $30.26M $34.18M $11.44M $3.25M $-3.08M $-6.80M $0.00M
FCFS Free Cash Flow Per Share
$2.31 $0.47 $0.07 $-0.93 $-1.14 $-0.08 $0.40 $0.67 $0.68 $1.76 $2.62 $2.05 $0.71 $2.18 $2.10 $2.42 $0.80 $0.23 $-0.21 $-0.49 $0.00